Clinicopathologic features and outcomes following surgery for pancreatic adenosquamous carcinoma

World Journal of Surgical Oncology - Tập 6 - Trang 1-6 - 2008
Jun-Te Hsu1, Han-Ming Chen2, Ren-Chin Wu3, Chun-Nan Yeh1, Ta-Sen Yeh1, Tsann-Long Hwang1, Yi-Yin Jan1, Miin-Fu Chen1
1Department of Surgery, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan
2Department of Surgery, Chung Shan Medical University Hospital, Chung Shan Medical University, Taichung, Taiwan
3Department of Pathology, Chang Gung Memorial Hospital, Chang Gung University College of Medicine, Taoyuan, Taiwan

Tóm tắt

Pancreatic adenosquamous carcinoma (ASC) is a rare pancreatic malignancy subtype. We investigated the clinicopathological features and outcome of pancreatic ASC patients after surgery. The medical records of 12 patients with pancreatic ASC undergoing surgical treatment (1993 to 2006) were retrospectively reviewed. Survival data of patients with stage IIB pancreatic adenocarcinoma and ASC undergoing surgical resection were compared. Symptoms included abdominal pain (91.7%), body weight loss (83.3%), anorexia (41.7%) and jaundice (25.0%). Tumors were located at pancreatic head in 5 (41.7%) patients, tail in 5 (41.7%), and body in 4 (33.3%). Median tumor size was 6.3 cm. Surgical resection was performed on 7 patients, bypass surgery on 3, and exploratory laparotomy with biopsy on 2. No surgical mortality was identified. Seven (58.3%) and 11 (91.7%) patients died within 6 and 12 months of operation, respectively. Median survival of 12 patients was 4.41 months. Seven patients receiving surgical resection had median survival of 6.51 months. Patients with stage IIB pancreatic ASC had shorter median survival compared to those with adenocarcinoma. Aggressive surgical management does not appear effective in treating pancreatic ASC patients. Strategies involving non-surgical treatment such as chemotherapy, radiotherapy or target agents should be tested.

Tài liệu tham khảo

Kardon DE, Thompson LD, Przygodzki RM, Heffess CS: Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Mod Pathol. 2001, 14: 443-451. 10.1038/modpathol.3880332.

Baylor SM, Berg JW: Cross-classification and survival characteristics of 5,000 cases of cancer of the pancreas. J Surg Oncol. 1973, 5: 335-338. 10.1002/jso.2930050410.

Motojima K, Tomioka T, Kohara N, Tsunoda T, Kanematsu T: Immunohistochemical characteristics of adenosquamous carcinoma of the pancreas. J Surg Oncol. 1992, 49: 58-62. 10.1002/jso.2930490114.

Yamaguchi K, Enjoji M: Adenosquamous carcinoma of the pancreas: a clinicopathologic study. J Surg Oncol. 1991, 47: 109-116. 10.1002/jso.2930470210.

Greence FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M: American Joint Committee on Cancer. AJCC cancer staging manual. 2002, New York: Springer, 159-160. 6

Herxheimer G: Uber heterologe Cancroide. Beitr Pathol Anat. 1907, 41: 348-412.

Al-Doroubi QI, Petrelli M, Reid JD: Adenoacanthoma of the sigmoid colon. Dis Colon Rectum. 1970, 13: 390-393. 10.1007/BF02616762.

Marshall D, Seldis A, Tcherkoff U: Adenoacnthoma of the corpus uteri with distant metastasis. Obstet Gynecol. 1963, 22: 578-582.

Kay S: Mucoepidermoid carcinoma of the esophagus. Cancer. 1968, 22: 1053-1059. 10.1002/1097-0142(196811)22:5<1053::AID-CNCR2820220522>3.0.CO;2-S.

Morson BC, Volkstadt H: Mucoepidermoid tumors of the anal canal. J Clin Pathol. 1963, 16: 200-205. 10.1136/jcp.16.3.200.

Sheets JL, Dockerty MB, Decker DG, Welch JS: Primary epithelial malignancy in the vagina. Am J Obstet Gynecol. 1964, 89: 121-129.

Rahemtullah A, Misdraji J, Pitman MB: Adenosquamous carcinoma of the pancreas: cytologic features in 14 cases. Cancer. 2003, 99: 372-378. 10.1002/cncr.11855.

Yeo CJ, Cameron JL, Sohn TA, Lillemoe KD, Pitt HA, Talamini MA, Hruban RH, Ord SE, Sauter PK, Coleman J, coleman J, Zahurak ML, Grochow LB, Abrams R: Six hundred fifty consecutive pancreaticoduodenectomies in the 1990s. Ann Surg. 1997, 3: 248-257. 10.1097/00000658-199709000-00004.